Soluble programmed death ligand-1 (sPD-L1): a pool of circulating proteins implicated in health and diseases
Simple Summary The interaction of programmed cell death ligand-1 (PDL1) with its receptor
PD1 inhibits T-cell responses. Blockade of this interaction with monoclonal antibodies leads …
PD1 inhibits T-cell responses. Blockade of this interaction with monoclonal antibodies leads …
Extracellular and nuclear PD-L1 in modulating cancer immunotherapy
Although targeting programmed death 1/programmed death ligand 1 (PD-1/PD-L1) has
achieved durable responses and disease remission in patients with certain cancers …
achieved durable responses and disease remission in patients with certain cancers …
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review …
JS Xue, H Liu, GX Meng, ZN Ding, LJ Yan… - Cancer Immunology …, 2021 - Springer
Background Preliminary studies have suggested that soluble programmed death-1 (sPD-1)
and soluble programmed cell death ligand-1 (sPD-L1) have prognostic implications in many …
and soluble programmed cell death ligand-1 (sPD-L1) have prognostic implications in many …